1. Home
  2. CSTE vs SLGL Comparison

CSTE vs SLGL Comparison

Compare CSTE & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.50

Market Cap

61.9M

Sector

Industrials

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$41.96

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
SLGL
Founded
1987
1997
Country
Israel
Israel
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.9M
69.1M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
CSTE
SLGL
Price
$1.50
$41.96
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$50.00
AVG Volume (30 Days)
471.1K
19.1K
Earning Date
11-12-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$400,656,000.00
$18,970,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
62.04
52 Week Low
$0.86
$4.02
52 Week High
$5.04
$52.26

Technical Indicators

Market Signals
Indicator
CSTE
SLGL
Relative Strength Index (RSI) 70.95 66.91
Support Level $0.86 $38.13
Resistance Level $1.05 $37.95
Average True Range (ATR) 0.13 3.88
MACD 0.07 0.86
Stochastic Oscillator 92.44 85.01

Price Performance

Historical Comparison
CSTE
SLGL

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: